Form ARS Enliven Therapeutics, For: Dec 31
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Enliven Therapeutics (ELVN) PT Lowered to $78 at Guggenheim
- TNT Explains What Makes High-Quality Whey Protein
- Bonerge Launches Clinical Trial Investigating Circadian Recovery in Night Shift Healthcare Workers
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
